In general, the diagnostic accuracy of the biomarker panel was similar to that of L-glutamic acid alone (0.91 vs 0.95), but much higher than that of pipecolic acid alone (0.91 vs 0.75) or AFP (0.91 vs 0.75) for MetS patients. This evidence concerns the gene AFP and metabolic syndrome.